Ligand non-competitive GITR antibody prevents formation of the obligatory signal-triggering GITRL: GITR stoichiometry

Yan Jing(Pfizer (United States)), Fridrik Karlsson(Louisiana State University Health Sciences Center Shreveport), Denise Murphy(Pfizer (United States)), Ting Chen(Pfizer (United States)), Ching-Shin Huang(Pfizer (United States)), Aaron Winkler(Pfizer (United States)), Caitlyn Dickinson(Pfizer (United States)), Małgorzata Nocula‐Ługowska(Pfizer (United States)), Lidia Mosyak(Pfizer (United States)), Jason Edmonds(Pfizer (United States)), Chad Stevens(Pfizer (United States)), Corey Dower(Pfizer (United States)), Susan Fish(Pfizer (United States)), Polina Goihberg(Pfizer (United States)), Jessica Haewon Min-DeBartolo(Boston University), Kerry Kelleher(Pfizer (United States)), Wei Zheng(University of Helsinki), Li Li(Pfizer (United States)), Heng Liu(ShanghaiTech University), M Sharif(Pfizer (United States)), Zachary Maben(University of Massachusetts Chan Medical School), Tatyana Andreyeva(Pfizer (United States)), Martin Hegen(Pfizer (United States))
Scientific Reports
December 18, 2025
Cited by 1


Related Papers